Artificial intelligence aids in development of nanomedicines for cancer management
P Tan, X Chen, H Zhang, Q Wei, K Luo - Seminars in cancer biology, 2023 - Elsevier
Over the last decade, the nanomedicine has experienced unprecedented development in
diagnosis and management of diseases. A number of nanomedicines have been approved …
diagnosis and management of diseases. A number of nanomedicines have been approved …
Strategies of Artificial intelligence tools in the domain of nanomedicine
Nanomedicine is a field of medicine that uses nanotechnology to develop new diagnostic
tools and therapies for a wide range of medical conditions. It encompasses a variety of …
tools and therapies for a wide range of medical conditions. It encompasses a variety of …
Artificial intelligence education: an evidence-based medicine approach for consumers, translators, and developers
FYC Ng, AJ Thirunavukarasu, H Cheng, TF Tan… - Cell Reports …, 2023 - cell.com
Current and future healthcare professionals are generally not trained to cope with the
proliferation of artificial intelligence (AI) technology in healthcare. To design a curriculum …
proliferation of artificial intelligence (AI) technology in healthcare. To design a curriculum …
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors
Background Hepatocellular carcinoma (HCC) remains difficult to treat due to limited effective
treatment options. While the proteasome inhibitor bortezomib has shown promising …
treatment options. While the proteasome inhibitor bortezomib has shown promising …
Microsystem advances through integration with artificial intelligence
Microfluidics is a rapidly growing discipline that involves studying and manipulating fluids at
reduced length scale and volume, typically on the scale of micro-or nanoliters. Under the …
reduced length scale and volume, typically on the scale of micro-or nanoliters. Under the …
[HTML][HTML] Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
It has been said that COVID-19 is a generational challenge in many ways. But, at the same
time, it becomes a catalyst for collective action, innovation, and discovery. Realizing the full …
time, it becomes a catalyst for collective action, innovation, and discovery. Realizing the full …
The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations
U Pagallo, S O'Sullivan, N Nevejans, A Holzinger… - Health and …, 2024 - Springer
Purpose This contribution explores the underuse of artificial intelligence (AI) in the health
sector, what this means for practice, and how much the underuse can cost. Attention is …
sector, what this means for practice, and how much the underuse can cost. Attention is …
[HTML][HTML] Addressing antimicrobial resistance with the IDentif. AI platform: Rapidly optimizing clinically actionable combination therapy regimens against …
Background: Current standard of care (SOC) regimens against nontuberculous
mycobacteria (NTM) usually result in unsatisfactory therapeutic responses, primarily due to …
mycobacteria (NTM) usually result in unsatisfactory therapeutic responses, primarily due to …
IDentif. AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 …
Nanomedicine-based and unmodified drug interventions to address COVID-19 have
evolved over the course of the pandemic as more information is gleaned and virus variants …
evolved over the course of the pandemic as more information is gleaned and virus variants …